“Cardiology is seeing a radical change in the management of aortic stenosis,” said Dr. Vinod H. Thourani.
DALLAS – Barriers to defining PROs include the disease’s variation from day to day and patients’ variations in desired outcomes.
DALLAS – The implanted PAP monitor maintains efficacy, safety in real-world use.
DALLAS – Events go up as ejection fraction declines.
Study in real-world setting shows more than sixfold higher risk for hemorrhagic stroke.
BARCELONA - Should all heart failure patients be monitored for atrial fibrillation?
T2DM sharply ups heart failure risk, but intensified multifactorial treatment reduces the risk.
DALLAS – Can phrenic nerve simulation succeed where adaptive servo-ventilation failed?
As cancer treatment options expand, so do their cardiac effects, and everyone caring for patients should be aware of them.
BARCELONA – Large U.K. study also shows mortality benefit.
Sildenafil performed worse than placebo in the SIOVAC trial.
Top outcomes in landmark trial came with achieved SBP of 130-140 mm Hg.
When it comes to measuring a patient’s blood pressure, “we do it wrong.”
As BMI goes up, mortality unexpectedly dropped in huge registry study.
BARCELONA – Sharply reduced stroke risk seen in first-ever RCT of LAA closure during open heart surgery.
BARCELONA – A FOURIER analysis showed that plunging LDL cholesterol below 10 mg/dL brings events down with it.
Diagnosis of syncope